Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2024.451 | A randomised, double-blind, placebo-controlled, multicentre, Phase III trial evaluating long-term efficacy and safety of survodutide weekly injections in adult participants with non-cirrhotic non-alcoholic steatohepatitis/metabolic associated steatohepatitis (NASH/MASH) and (F2) - (F3) stage of liver fibrosis |
Prof. WONG Vincent Wai Sun Wai Sun Vincent Wong |
| 2024.124 | Assessing the safety of discontinuing non-selective beta-blockers in cirrhotic patients with managed primary aetiological factors according to Baveno VII consensus |
Professor Wong Vincent Wai Sun 黃煒燊 |
| 2024.292 | A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis |
Prof. WONG Vincent Wai Sun 黃煒燊 |
| 2024.440 | A Phase III double-blind, randomised, placebo-controlled trial to evaluate liver-related clinical outcomes and safety of once weekly injected survodutide in participants with compensated non-alcoholic steatohepatitis/metabolic dysfunction associated steatohepatitis (NASH/MASH) cirrhosis |
Prof. WONG Vincent Wai Sun Wai Sun Vincent Wong |
| 2006.439 | Collection of Blood and Liver Biopsy Samples for Liver Fibrosis Study | Dr. WONG Vincent Wai Sun |
| 2017.166 | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH) |
Prof. WONG Vincent Wai Sun 黃煒燊 |
| 2016.698 | Non-invasive diagnosis and prognosis of nonalcoholic steatohepatitis and liver fibrosis: A clinicopathological study of metabolite, lipid, and protein biomarkers |
Dr. WONG Vincent Wai Sun 黃煒燊 |
| 2014.586 | CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects with Liver Fibrosis | Prof. WONG Vincent Wai Sun |
| 2017.258 | AURORA: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis |
Prof. WONG Vincent Wai Sun 黃煒燊 |
| 2017.257 | Open-label Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis (NASH) |
Prof. WONG Vincent Wai Sun 黃煒燊 |
| 2017.511 | Biomarkers study on biological samples from NAFLD and NASH patients from the biobank at the Chinese University of Hong Kong |
Dr. WONG Vincent Wai Sun 黃煒燊 |
| 2016.606 | A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with Nonalcoholic Steatohepatitis (NASH) |
Prof. WONG Vincent Wai Sun 黃煒燊 |
| 2017.611 | A 12-week randomized, patient and investigator blinded, placebo-controlled, parallel group study to investigate the efficacy of LIK066 in obese patients with non-alcoholic steatohepatitis (NASH) |
Prof. WONG Vincent Wai Sun 黃煒燊 |
| 2017.001 | Optimizing varices screening in cirrhotic patients with well-controlled chronic viral hepatitis: A prospective cohort study with transient elastography and multiparametric magnetic resonance imaging |
Dr. WONG Vincent Wai Sun 黃煒燊 |
| 2017.422 | A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Subjects with Primary Biliary Cholangitis |
Prof. WONG Vincent W.S. 黃偉燊 |
| 2003.338 | A Study on Nonalcoholic Steatohepatitis (NASH) in Hong Kong | Prof. WONG Vincent W.S. |
| 2013.678 | Brown adipose tissue and body fat distribution in non-alcoholic steatohepatitis: A clinicopathological study using fat-water magnetic resonance imaging | Dr Wong Vincent |
| 2025.071 | Prevalence and clinical significance of detectable blood phosphatidylethanol in patients with metabolic dysfunction-associated steatotic liver disease and chronic hepatitis B |
Dr. WONG Vincent Vincent Wong |
| 2018.236 | Prevalence and severity of chronic liver diseases among patients with psychiatric illness: A cross-sectional study using transient elastography |
Dr. WONG Vincent 黃煒燊 |
| 2020.304 | SGLT2 inhibitors and liver-related outcomes in patients with type 2 diabetes mellitus: A territory-wide retrospective cohort study |
Dr. WONG Vincent 黃煒燊 |
| 2019.139 | Identification of fatty liver with advanced fibrosis in patients with type 2 diabetes using simple fibrosis scores and electronic reminder messages: A randomized controlled trial |
Dr. WONG Vincent 黃煒燊 |
| 2019.136 | Characterization of biology of nonalcoholic fatty liver disease by single-cell RNA sequencing |
Dr. WONG Vincent 黃煒燊 |
| 2018.230 | Incidence of liver-related events among patients with psychiatric illness: A retrospective cohort study |
Dr. WONG Vincent 黃煒燊 |
| 2023.471 | Validation and refinement of serum multi-OMIC signature for identifying liver fibrosis and metabolic dysfunction-associated steatohepatitis in the Asian population |
Dr. WONG Vincent 黃煒燊 |
| 2022.208 | Clinical and prognostic significance of intrahepatic fibroblast activation protein expression in patients with non-alcoholic fatty liver disease |
Dr. WONG Vincent 黃煒燊 |
| 2022.255 | Prognostic implication of baseline and changes in liver stiffness measurement and the FibroScan-aspartate aminotransferase (FAST), Agile 3+ and Agile 4 scores in patients with non-alcoholic fatty liver disease: A retrospective cohort study |
Dr. WONG Vincent 黃煒燊 |
| 2022.622 | A Phase IIb/III Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Cotadutide in Participants with Non-cirrhotic Non-alcoholic Steatohepatitis with Fibrosis |
Prof. WONG Vincent 黃煒燊 |
| 2023.436 | Monitoring changes in hepatic steatosis during a lifestyle intervention programme in patients with non-alcoholic fatty liver disease using the novel continuous controlled attenuation parameter versus MRI proton density fat fraction |
Dr. WONG Vincent 黃煒燊 |
| 2021.606 | Viral Load and Hepatocellular Carcinoma Risk in Chronic Hepatitis B: Time to Consider Extended Treatment Indications |
Dr. WONG Vincent 黃煒燊 |
| 2021.634 | Gut microbiome and metabolites in Non-alcoholic fatty liver diseases |
Prof. WONG Vincent 黃煒燊 |
| 2017.310 | Predicting fibrosis progression in patients with non-alcoholic fatty liver disease using clinical, genetic and baseline histological assessments: A prospective cohort study |
Dr. WONG Vincent 黃煒燊 |
| 2017.703 | Automated fibrosis staging in nonalcoholic fatty liver disease: A retrospective cohort study using the dual-photon microscopy technology |
Dr. WONG Vincent 黃煒燊 |
| 2015.495 | Novel magnetic resonance imaging patients with chronic liver diseases – a cross-sectional study with histological correlation |
Dr. WONG Vincent 黃煒燊 |
| 2015.505 | Incidence of non-alcoholic fatty liver disease and advanced fibrosis in patients with type 2 diabetes: A prospective cohort study using paired controlled attenuation parameter and liver stiffness measurements |
Dr. WONG Vincent 黃煒燊 |
| 2015.452 | Prognostication of nonalcoholic fatty liver disease and chronic hepatitis B with controlled attenuation parameter and liver stiffness measurement by Fibroscan – A prospective cohort study |
Dr. WONG Vincent 黃煒燊 |
| 2014.691 | Prediction of hepatocellular carcinoma with serum methylated RASSF1A in patients with chronic hepatitis B on antiviral therapy: A longitudinal study | Dr Wong Vincent |
| 2013.677 | Consolidation of lifestyle modification program with mobile phone text messaging in patients with non-alcoholic fatty liver disease: A randomized controlled trial | Dr Wong Vincent |
| 2017.509 | Myositis specific autoantibodies and their clinical association in idiopathic inflammatory myopathies in Hong Kong | Dr. WONG Victor Tak Lung |
| 2011.280 | Evaluation of Skin pruritus among patients with recovery from burn injury | Ms. Wong Tze Wing |
| 2009.293 | A cross-sectional study of the prevalence of tinea pedis and onychomycosis in Hong Kong | Prof Wong Tze Wai |
| 2023.675 | Comparing the effects of plyometrics and isotonic strength training on vertical jump height in volleyball players |
Miss. WONG Tsz Wai 黃芷蔚 |
| 2011.270 | Admission Screening Study of Methicillin-Resistant Staphylococcus aureus (MRSA) in acute care hospitals in Hospital Authority (HA) | Dr Wong Tin-yau |
| 2016.647 | Effects of a Physical Restraint Reduction Program in Rehabilitation Hospital | Mr. WONG Timothy |
| 2020.230 | Clinical characteristics of Hong Kong COVID-19 paediatric patients | Dr. WONG Tak Wai |
| 2020.286 | Impact of COVID-19 on children and family members | Dr. WONG Tak Wai |
| 2011.139 | Investigating the Epidemiology of Inflammatory Bowel Disease in Hong Kong: An Inception Cohort and Follow up Study (IBD EPI Study) | Dr Wong Tai Chiu |
| 2012.359 | Interventions of Functional incontinence for Elderly Female Patients in Hosptials: A Control Study | Miss Wong Sze Wing |
| 2009.181 | MiCo-Mirena or conventional medical treatment for menorrhagia | Dr. Wong Sze Wai |
| 2013.450 | What should be the endometrial thickness cut–off value for detection of endometrial hyperplasia or carcinoma in women with postmenopausal bleeding-analysis of data from over 2500 patients in a dedicated postmenopausal bleeding clinic | Dr Wong Sze Wai |
| 2013.510 | Mortality among Demented Patients with Behavioral and Psychological Symptoms (BPSD) Receiving Antipsychotic Treatments | Dr. Wong Sze Nga |
Page 25 of 264.